Position in SRPT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$128,898
-$27,186 QoQ
Shares Held
7,173
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#212
of 320 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WESTPAC BANKING CORP holds $6,758,867 across 5 Biotechnology names. SRPT ranks #5 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,059 | $4,401,567 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,614 | $1,298,451 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,632 | $792,310 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
1,583 | $137,641 | |
| 5 | SRPT |
Sarepta Therapeutics, Inc.
This page
|
7,173 | $128,898 |
All Filings in SRPT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $128,898 | 7,173 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $156,084 | 7,173 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $154,362 | 7,173 | Shares | Defined | 2026-02-10 | |
| 2021-03-31 | $470,955 | 6,319 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,077,326 | 6,319 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $887,377 | 6,319 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $1,013,188 | 6,319 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $618,124 | 6,319 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||